Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Gastric Volvulus Treatment Market Size From 2025 to 2034?
In recent times, the market size for gastric volvulus treatment has seen a significant increase. It’s anticipated to expand from $27.36 billion in 2024 and reach $28.86 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to the growth during the historic period include advancements in surgical methodologies, enhancement of diagnostic technologies, increased awareness and education, a surge in minimally invasive procedures, and ongoing research and clinical studies.
A solid expansion is anticipated in the gastric volvulus treatment market, which is predicted to reach a size of $37.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. This growth trajectory over the specified forecast period can be credited to regulatory updates and authorizations, surgical procedure innovations, an increasing elderly population, personalized treatment strategies, and the embracing of high-tech imaging techniques. Key trends predicted for this period include the prevalence of minimally invasive surgery, increased awareness leading to early interventions, research into different treatment modalities, cooperation in medical practice, and the tailoring of treatment methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
What are the Fundamental Drivers and Innovations Shaping the Gastric Volvulus Treatment Market?
The growth of the gastric volvulus treatment market is projected to be driven by an increasing geriatric population. This term is used to describe individuals aged 65 years and over, who tend to suffer from numerous diseases due to their age and declining immunity. Gastric volvulus, in particular, typically affects older adults over the age of 50. Therefore, the expanding geriatric demographic is likely to fuel this market. For example, the Population Reference Bureau (PRB), a nonprofit organization based in the US, released data in January 2024 suggesting that the American population aged 65 and above is estimated to rise from 58 million in 2022 to 82 million in 2050, marking a 47% increase. Furthermore, their proportion within the total population is predicted to grow from 17% to 23%. Hence, the swelling numbers of older adults are contributing to market growth for gastric volvulus treatments.
How Is the Gastric Volvulus Treatment Market Segmented?
The gastric volvulus treatmentmarket covered in this report is segmented –
1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus
2) By Treatment Type: Medication; Surgery
3) By Route Of Administration: Oral; Parenteral
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp
Which Regions Are Driving the Next Phase of the Gastric Volvulus Treatment Market Growth?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Trends Are Shaping the Future of the Gastric Volvulus Treatment Market?
The advent of product innovations is a notable trend escalating in prominence in the gastric volvulus treatment market. Leading corporations in this sector are launching revolutionary merchandise to maintain their presence in this market. For instance, Pfizer Inc., a pharmaceutical firm based in the US, announced in October 2023 that the US Food and Drug Administration (FDA) had given approval for VELSIPITY (etrasimod). This is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator intended for people suffering from moderate to severe active ulcerative colitis (UC). The recommended dosage for VELSIPITY is set at 2 mg. It offers adults with moderately to severely active UC, the possibility of achieving steroid-free resolution with a once-daily, orally-administered pill that boasts a favourable benefit-risk ratio. The FDA’s consent rendered to VELSIPITY marks a critical milestone for UC patients in need of innovative treatments for their long-term ailment and are prepared to commence advanced therapy.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
How Is the Gastric Volvulus Treatment Market Defined and What Are Its Core Parameters?
Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is usually simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model